Shanghai Henlius Biotech, Inc. (HKG:2696)
69.00
+4.25 (6.56%)
At close: Mar 6, 2026
146.43% (1Y)
| Market Cap | 37.50B |
| Revenue (ttm) | 6.35B |
| Net Income (ttm) | 903.25M |
| Shares Out | 543.49M |
| EPS (ttm) | 1.66 |
| PE Ratio | 41.52 |
| Forward PE | 40.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,273,200 |
| Average Volume | 1,381,951 |
| Open | 64.75 |
| Previous Close | 64.75 |
| Day's Range | 64.70 - 69.35 |
| 52-Week Range | 23.00 - 92.00 |
| Beta | 0.59 |
| RSI | 57.27 |
| Earnings Date | Mar 20, 2026 |